Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2025-02-25 00:00:00 ET · period of report 2025-02-24 · accession 0001628280-25-007708 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-25 | 2025-02-24 | VIR | SCANGOS GEORGE A | Dir | S - Sale | $9.45 | -10.1K | 698.2K | -1% | -$95.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-24 | S | D | 10,056 | $9.45 | 698,239 | D | — | — |